Literature DB >> 20433802

Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice.

Chuan Li1, Feng Liu, Mifang Liang, Quanfu Zhang, Xiaofang Wang, Tao Wang, Jiandong Li, Dexin Li.   

Abstract

A safe and effective hantavirus vaccine is highly desirable since hantaviruses are distributed worldwide and cause an acute and often fatal disease (hemorrhagic fever with renal syndrome, HFRS). Virus-like particles (VLPs) displaying functional viral proteins could provide effective vaccines against a few viruses, but their ability to induce hantavirus-specific immune response has not been adequately investigated. To measure the immunogenicity of Hantaan virus-like particles (HTN-VLPs) vaccine, we generated recombinant HTN-VLPs by co-expressing Hantaan virus nucleocapsid (N) protein and glycoproteins (Gn and Gc) in Chinese hamster ovary (CHO) cells. We compared intramuscular versus subcutaneous administration of HTN-VLPs for the ability to induce specific immune response against Hantaan virus infection. Mice that received both intramuscular and subcutaneous immunizations of HTN-VLPs were sufficiently stimulated specific antibody response against Hantaan virus N protein and glycoproteins, which was comparable to Chinese commercial inactivated bivalent hantaviruses vaccine. Moreover, vaccination with HTN-VLPs also resulted in the induction of higher levels of specific cellular response to N protein than that of inactivated vaccine. Our results provide an important insight towards the development of hantaviruses-like particles as a potential candidate vaccine for the control and prevention of hantaviruses infection. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20433802     DOI: 10.1016/j.vaccine.2010.04.025

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  25 in total

1.  Hantavirus Gn and Gc glycoproteins self-assemble into virus-like particles.

Authors:  Rodrigo Acuña; Nicolás Cifuentes-Muñoz; Chantal L Márquez; Manuela Bulling; Jonas Klingström; Roberta Mancini; Pierre-Yves Lozach; Nicole D Tischler
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

2.  Detection of new bunyavirus RNA by reverse transcription-loop-mediated isothermal amplification.

Authors:  Xue-Yong Huang; Xiao-Ning Hu; Hong Ma; Yan-Hua Du; Hong-Xia Ma; Kai Kang; Ai-Guo You; Hai-Feng Wang; Li Zhang; Hao-Min Chen; J Stephen Dumler; Bian-Li Xu
Journal:  J Clin Microbiol       Date:  2013-12-04       Impact factor: 5.948

3.  Fever with thrombocytopenia associated with a novel bunyavirus in China.

Authors:  Xue-Jie Yu; Mi-Fang Liang; Shou-Yin Zhang; Yan Liu; Jian-Dong Li; Yu-Lan Sun; Lihong Zhang; Quan-Fu Zhang; Vsevolod L Popov; Chuan Li; Jing Qu; Qun Li; Yan-Ping Zhang; Rong Hai; Wei Wu; Qin Wang; Fa-Xian Zhan; Xian-Jun Wang; Biao Kan; Shi-Wen Wang; Kang-Lin Wan; Huai-Qi Jing; Jin-Xin Lu; Wen-Wu Yin; Hang Zhou; Xu-Hua Guan; Jia-Fa Liu; Zhen-Qiang Bi; Guo-Hua Liu; Jun Ren; Hua Wang; Zhuo Zhao; Jing-Dong Song; Jin-Rong He; Tao Wan; Jing-Shan Zhang; Xiu-Ping Fu; Li-Na Sun; Xiao-Ping Dong; Zi-Jian Feng; Wei-Zhong Yang; Tao Hong; Yu Zhang; David H Walker; Yu Wang; De-Xin Li
Journal:  N Engl J Med       Date:  2011-03-16       Impact factor: 91.245

Review 4.  Human pathogenic hantaviruses and prevention of infection.

Authors:  Detlev H Krüger; Günther Schönrich; Boris Klempa
Journal:  Hum Vaccin       Date:  2011-06-01

5.  Hantavirus entry: Perspectives and recent advances.

Authors:  Eva Mittler; Maria Eugenia Dieterle; Lara M Kleinfelter; Megan M Slough; Kartik Chandran; Rohit K Jangra
Journal:  Adv Virus Res       Date:  2019-08-07       Impact factor: 9.937

6.  Effects of Different Doses of Nucleocapsid Protein from Hantaan Virus A9 Strain on Regulation of Interferon Signaling.

Authors:  Wen Pan; Gang Bian; Kezhen Wang; Tingting Feng; Jianfeng Dai
Journal:  Viral Immunol       Date:  2015-07-21       Impact factor: 2.257

7.  Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice.

Authors:  Shuo Zhang; Mifang Liang; Wen Gu; Chuan Li; Fang Miao; Xiaofang Wang; Cong Jin; Li Zhang; Fushun Zhang; Quanfu Zhang; Lifang Jiang; Mengfeng Li; Dexin Li
Journal:  Virol J       Date:  2011-06-30       Impact factor: 4.099

8.  An overview on the field of micro- and nanotechnologies for synthetic Peptide-based vaccines.

Authors:  Aiala Salvador; Manoli Igartua; Rosa Maria Hernández; José Luis Pedraz
Journal:  J Drug Deliv       Date:  2011-06-15

9.  Fusion with extracellular domain of cytotoxic T-lymphocyte-associated-antigen 4 leads to enhancement of immunogenicity of Hantaan virus DNA vaccines in C57BL/6 mice.

Authors:  Feng Liu; Mifang Liang; Shouchun Cao; Qinzhi Liu; Quanfu Zhang; Chuan Li; Shuo Zhang; Shiwen Wang; Dexin Li
Journal:  Virol J       Date:  2011-09-23       Impact factor: 4.099

Review 10.  Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses.

Authors:  Joseph W Golden; Christopher D Hammerbeck; Eric M Mucker; Rebecca L Brocato
Journal:  Biomed Res Int       Date:  2015-07-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.